Clear Street analyst Bill Maughan reiterated a Buy rating and $18.00 price target on Ocular Therapeutix (NASDAQ: OCUL).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Raymond James Reiterates Strong Buy Rating on Ocular Therapeutix (OCUL)August 5, 2025 11:07 AM Ocular Therapeutix (OCUL) Misses Q2 EPS by 4cAugust 5, 2025 7:13 AM Form 10-Q OCULAR THERAPEUTIX, INC For: Jun 30August 5, 2025 7:11 AM Form 8-K OCULAR THERAPEUTIX, INC For: Aug 05August 5, 2025 7:06 AM Ocular Therapeutix™ Reports Second Quarter 2025 Financial Results and Business HighlightsAugust 5, 2025 7:01 AM Raymond James Reiterates Strong Buy Rating on Ocular Therapeutix (OCUL)August 4, 2025 1:18 PM